blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2599793

EP2599793 - Anti-phospho-akt antibodies [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.05.2014
Database last updated on 19.10.2024
Most recent event   Tooltip02.05.2014Application deemed to be withdrawnpublished on 04.06.2014  [2014/23]
Applicant(s)For all designated states
Nuclea Biotechnologies, Inc.
46 Elm Street
Pittsfield, MA 01201 / US
[N/P]
Former [2013/23]For all designated states
Nuclea Biotechnologies, Inc.
46 Elm Street
Pittsfield, MA 01210 / US
Inventor(s)01 / Muraca, Patrick J.
105 South Street
Pittsfield, MA 01201-6174 / US
 [2013/23]
Representative(s)Forstmeyer, Dietmar, et al
Boeters & Lieck
Oberanger 32
80331 München / DE
[N/P]
Former [2013/23]Forstmeyer, Dietmar, et al
Boeters & Lieck Oberanger 32
80331 München / DE
Application number, filing date12008670.727.05.2009
[2013/23]
Priority number, dateUS20080130198P29.05.2008         Original published format: US 130198 P
[2013/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2599793
Date:05.06.2013
Language:EN
[2013/23]
Search report(s)(Supplementary) European search report - dispatched on:EP06.05.2013
ClassificationIPC:C07K16/32, G01N33/68, A61K39/395
[2013/23]
CPC:
A61K31/00 (EP,US); G01N33/5748 (US); A61K39/39558 (EP,US);
A61K45/06 (EP,US); A61P35/00 (EP); C07K16/32 (EP,US);
G01N33/68 (EP,US); A61K2039/505 (EP,US); G01N2333/91205 (US);
G01N33/53 (US) (-)
C-Set:
A61K39/39558, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2013/23]
TitleGerman:Anti-Phosphor-AKT-Antikörper[2013/23]
English:Anti-phospho-akt antibodies[2013/23]
French:Anticorps anti-phospho-akt[2013/23]
Examination procedure06.12.2013Application deemed to be withdrawn, date of legal effect  [2014/23]
14.01.2014Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2014/23]
Parent application(s)   TooltipEP09759057.4  / EP2304439
Fees paidRenewal fee
31.12.2012Renewal fee patent year 03
31.12.2012Renewal fee patent year 04
23.05.2013Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[IY]WO0037613  (JANSSEN PHARMACEUTICA NV [BE], et al) [I] 1-6,9,10 * claims 20-24 * * sequence 3 * [Y] 8;
 [I]WO0056866  (AVENTIS PHARM PROD INC [US], et al) [I] 1-5 * page 23, line 25 - page 26, line 7 * * claims 23-24 * * sequence 2 *;
 [I]  - STANLEY F. BARNETT ET AL, "Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors", BIOCHEMICAL JOURNAL, (20050115), vol. 385, no. 2, doi:10.1042/BJ20041140, ISSN 0264-6021, pages 399 - 408, XP055060694 [I] 1-5 * page 402, column l, paragraph l - column r, paragraph 2 *

DOI:   http://dx.doi.org/10.1042/BJ20041140
 [I]  - ARBOLEDA M JANE ET AL, "Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (20030101), vol. 63, no. 1, ISSN 0008-5472, pages 196 - 206, XP002299905 [I] 1-5 * page 198, column l, paragraph 4 *
 [Y]  - S BAUER ET AL, "KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway", ONCOGENE, (20071129), vol. 26, no. 54, doi:10.1038/sj.onc.1210558, ISSN 0950-9232, pages 7560 - 7568, XP055060756 [Y] 8 * page 7561, column l, paragraph 2 * * page 7567, column l, paragraph 2 - paragraph 4 *

DOI:   http://dx.doi.org/10.1038/sj.onc.1210558
 [Y]  - L TORNILLO, "An update on molecular genetics of gastrointestinal stromal tumours", JOURNAL OF CLINICAL PATHOLOGY, (20060210), vol. 59, no. 6, doi:10.1136/jcp.2005.031112, ISSN 0021-9746, pages 557 - 563, XP055060760 [Y] 8 * the whole document *

DOI:   http://dx.doi.org/10.1136/jcp.2005.031112
by applicantUS3867517
 US3940475
 US4289747
 US4302438
 US4376110
 US4414148
 US4444887
 WO8403508
 US4474893
 WO8503508
 US4631211
 EP0239400
 US4714681
 US4716111
 US4816567
 US4816397
 WO9002809
 US4925648
 US4946778
 WO9100360
 WO9109967
 WO9110737
 WO9110741
 WO9201047
 WO9205793
 WO9208802
 WO9218619
 EP0519596
 WO9311236
 US5223409
 US5225539
 WO9317715
 US5258498
 EP0592106
 EP0598877
 US5403484
 US5413923
 WO9515982
 US5427908
 WO9520401
 US5516637
 US5530101
 US5545806
 US5565332
 US5569825
 WO9634096
 WO9633735
 US5571698
 US5573920
 US5580717
 US5585089
 US5601819
 US5625126
 US5633425
 US5658727
 US5661016
 US5693762
 WO9746251
 US5698426
 US5733743
 WO9816654
 US5750753
 WO9824893
 US5780225
 US5807715
 US5814318
 US5821047
 WO9846645
 WO9850433
 US5885793
 US5916771
 US5939598
 US5969108
 US6075181
 US6114598
    - FRANKE, T.F., CELL, (1997), vol. 88, pages 435 - 437
    - COFFER, P.J., NATURE, (1995), vol. 376, pages 599 - 602
    - FRANKE, T.F. ET AL., CELL, (1995), vol. 81, pages 727 - 736
    - ALESSI, D.R. ET AL., EMBOJ, (1996), vol. 15, pages 6541 - 6551
    - SARBASSOV, D.D. ET AL., SCIENCE, (2005), vol. 307, pages 1098 - 1101
    - JACINTO, E. ET AL., CELL, (2006), vol. 127, pages 125 - 137
    - CARDONE, M.H. ET AL., SCIENCE, (1998), vol. 282, pages 1318 - 1321
    - BRUNET, A. ET AL., CELL, (1999), vol. 96, pages 857 - 868
    - ZIMMERMAN, S. ET AL., SCIENCE, (1999), vol. 286, pages 1741 - 1744
    - CANTLEY, L.C. ET AL., PROC. NATL. ACAD. SCI., USA, (1999), vol. 96, pages 4240 - 4245
    - VLAHOS, C. ET AL., J BIOL. CHEM., (1994), vol. 269, pages 5241 - 5248
    - HAJDUCH, E. ET AL., FEBS LETT., (2000), vol. 492, pages 199 - 203
    - CROSS, D.A. ET AL., NATURE, (1995), vol. 373, pages 785 - 789
    - DIEHL, J.A. ET AL., GENES DEV., (1998), vol. 12, pages 3499 - 3511
    - GESBERT, F. ET AL., J BIOL. CHEM., (2000), vol. 275, pages 39223 - 39230
    - ZHOU, B.P. ET AL., NAT. CELL BIOL, (2001), vol. 3, pages 245 - 252
    - NAVE, B.T. ET AL., BIOCHEM. J., (1999), vol. 344, pages 427 - 431
    - MANNING, B.D. ET AL., BIOCHEM. SOC. TRANS., (2003), vol. 31, no. 3, pages 573 - 8
    - MANNING, B.D. ET AL., MOL. CELL, (2002), vol. 10, pages 151 - 162
    - INOKI, K. ET AL., NAT. CELL BIOL., (2002), vol. 4, pages 648 - 657
    - LU, Y. ET AL., JBIOL CHEM., (2003), vol. 278, no. 41, pages 40057 - 40066
    - SIGNORETTI ET AL., J NAT. CANCER INST., (2000), vol. 92, no. 23, page 1918
    - HOUGHTEN, PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, pages 5131 - 5135
    - ANDERSSON ET AL., BIOPOLYMERS, (2000), vol. 55, pages 227 - 250
    - MERRIFIELD, R. B., J ARN. CHEM. SOC., (1963), vol. 85, pages 2149 - 2154
    - KOHLER; MILSTEIN, NATURE, (1975), vol. 256, pages 495 - 497
    - IYER ET AL., IND. J MED. RES., (2000), vol. 123, pages 561 - 564
    - TUTT ET AL., J. IMRNUNOL., (1991), vol. 147, pages 60 - 69
    - KOSTELNY ET AL., J IMMUNOL., (1992), vol. 148, pages 1547 - 1553
    - KOHLER; MILSTEIN, NATURE, (1975), vol. 256, page 495
    - GODING, Monoclonal Antibodies: Principles and Practice, ACADEMIC PRESS, (1986), pages 59 - 1031
    - KOZBOR, IMMUNOL., (1984), vol. 133, page 3001
    - BRODEUR ET AL., Monoclonal Antibody Production Techniques and Applications, MARCEL DEKKER, INC., (1987), pages 51 - 63
    - FUKUMA ET AL., AUTOIMMUNITY, (1991), vol. 10, no. 4, pages 291 - 195
    - MUNSON; POLLARD, ANAL. BIOCHEM., (1980), vol. 107, page 220
    - BRINKMAN ET AL., J IMMUNOL. METHODS, (1995), vol. 182, pages 41 - 50
    - AMES ET AL., J. IMMUNOL. METHODS, (1995), vol. 184, pages 177 - 186
    - KETTLEBOROUGH ET AL., EUR. J. IMMUNOL., (1994), vol. 24, pages 952 - 958
    - PERSIC ET AL., GENE, (1997), vol. 187, pages 9 - 18
    - BURTON ET AL., ADVANCES IN IMMUNOLOGY, (1994), vol. 57, pages 191 - 280
    - HUSTON ET AL., METHODS IN ENZYMOLOGY, (1991), vol. 203, pages 46 - 88
    - SHU ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 7995 - 7999
    - SKERRA ET AL., SCIENCE, (1988), vol. 240, pages 1038 - 1040
    - MORRISON, SCIENCE, (1985), vol. 229, page 1202
    - OI ET AL., BIOTECHNIQUES, (1986), vol. 4, page 214
    - GILLIES ET AL., J. IRNRNUNOL. METHODS, (1989), vol. 125, pages 191 - 202
    - RIECHMANN ET AL., NATURE, (1988), vol. 332, page 323
    - PADLAN, MOLECULAR IMMUNOLOGY, (1991), vol. 28, no. 4-5, pages 489 - 498
    - STUDNICKA ET AL., PROTEIN ENGINEERING, (1994), vol. 7, no. 6, pages 805 - 814
    - ROGUSKA ET AL., PROC. NATL. ACAD. SCI. USA, (1994), vol. 91, pages 969 - 973
    - LONBERG; HUSZAR, INTL. REV. IMMUNOL., (1995), vol. 13, pages 65 - 93
    - NASH ET AL., IMMUNOLOGY, (1989), vol. 68, pages 332 - 340
    - FUKUMA ET AL., AUTOIRNRNUNITY, (1991), vol. 10, no. 4, pages 291 - 195
    - D. COLCHER ET AL., "Use of Monoclonal Antibodies as Radiopharmaceuticals for the Localization of Human Carcinoma Xenografts in Athymic Mice", METH. ENZYMOL., (1986), vol. 121, pages 802 - 816
    - HUNTER; GREENWOOD, NALURE, (1962), vol. L44, page 945
    - DAVID ET AL., BIOCHEMISTRY, (1974), vol. 13, pages 1014 - 1021
    - GREENWOOD, F. ET AL., BIOCHEM. J., (1963), vol. 89, pages 114 - 123
    - MARCHALONIS, J., BIOCHEM. J., (1969), vol. 113, pages 299 - 305
    - MORRISON, M. ET AL., IMMUNOCHEMISTRY, (1971), pages 289 - 297
    - RHODES, B. ET AL., Tumor Imaging: The Radioimmunochemical Detection of Cancer, MASSON, (1982), pages 111 - 123
    - HNATOWICH, D.J. ET AL., IMMUL. METHODS, (1983), vol. 65, pages 147 - 157
    - HNATOWICH, D. ET AL., J. APPLIED RADIATION, (1984), vol. 35, pages 554 - 557
    - BUCKLEY, R. G. ET AL., F.E.B.S., (1984), vol. 166, pages 202 - 204
    - "Developments in Antibody Imaging", A. R. BRADWELL ET AL., Monoclonal Antibodies for Cancer Detection and Therapy, ACADEMIC PRESS, (1985), pages 65 - 85
    - STRYER, SCIENCE, (1968), vol. 162, page 526
    - BRAND, L. ET AL., ANNUAL REVIEW OF BIOCHEMISTRY, (1972), vol. 41, pages 843 - 868
    - PYKETT, SCIENTIFIC AMERICAN, (1982), vol. 246, pages 78 - 88
    - FLECHNER, I, EUROPEAN JOURNAL OF CANCER, (1973), vol. 9, pages 741 - 745
    - GHOSE, T. ET AL., BRITISH MEDICAL JOURNAL, (1972), vol. 3, pages 495 - 499
    - SZEKERKE, M. ET AL., NEOPLASMA, (1972), vol. 19, pages 211 - 215
    - HURWITZ, E ET AL., CANCER RESEARCH, (1975), vol. 35, pages 1175 - 1181
    - ARNON, R. ET AL., CANCER SURVEYS, (1982), vol. 201, pages 429 - 449
    - OSAWA, T. ET AL., CANCER SURVEYS, (1982), vol. 1, pages 373 - 388
    - "Analysis, Results, and Future Prospective of the Therapeutic Use of Radiolabeled Antibody in Cancer Therapy", S. E. ORDER ET AL., Monoclonal Antibodies for Cancer Detection and Therapy, ACADEMIC PRESS, (1985), pages 303 - 316
    - IYER ET AL., IND. J. MED. RES., (2006), vol. 123, pages 651 - 564
    - SIGNORETTI ET AL., J NATL. CANCER INSTIT., (2000), vol. 92, no. 23, pages 1918 - 25
    - GU ET AL., ONCOGENE, (2000), vol. 19, pages 1288 - 96
 EP19860309516
 WO1991GB01134
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.